Progression of echocardiographic parameters and prognosis in transthyretin cardiac amyloidosis

AIMS: Transthyretin amyloid cardiomyopathy (ATTR‐CM) is an increasingly diagnosed disease. Echocardiography is widely utilized, but studies to confirm the value of echocardiography for tracking changes over time are not available. We sought to describe (i) changes in multiple echocardiographic parameters; (ii) differences in rate of progression of three predominant genotypes; and (iii) the ability of changes in echocardiographic parameters to predict prognosis. METHODS AND RESULTS: We prospectively studied 877 ATTR‐CM patients attending our centre between 2000 and 2020. Serial echocardiography findings at baseline, 12 months and 24 months were compared with survival. Overall, 565 patients had wild‐type ATTR‐CM and 312 hereditary ATTR‐CM (201 with V122I; 90 with T60A). There was progressive worsening of structural and functional parameters over time, patients with V122I ATTR‐CM showing more rapid worsening of left and right ventricular structural and functional parameters compared to both wild‐type and T60A ATTR‐CM. Among a wide range of echocardiographic analyses, including deformation‐based parameters, only worsening in the degree of mitral (MR) and tricuspid regurgitation (TR) at 12‐ and 24‐month assessments was associated with worse prognosis (change at 12 months: MR, hazard ratio 1.43 [95% confidence interval 1.14–1.80], p = 0.002; TR, hazard ratio 1.38 [95% confidence interval 1.10–1.75], p = 0.006). Worsening in MR remained independently associated with poor prognosis after adjusting for known predictors. CONCLUSION: In ATTR‐CM, echocardiographic parameters progressively worsen over time. Patients with V122I ATTR‐CM demonstrate the most rapid deterioration. Worsening of MR and TR were the only parameters associated with mortality, MR remaining independent after adjusting for known predictors.